
CRISPR knockout cell lines are engineered through targeted genome editing to eliminate gene function, supporting studies of cellular biology, disease mechanisms, and drug discovery.
GPR65 (G protein-coupled receptor 65) encodes a G protein-coupled receptor that is located in the plasma membrane and responds to acidic extracellular conditions. It participates in G protein-coupled receptor signaling and is involved in processes including activation of GTPase activity and positive regulation of stress fiber assembly. Through its pH-responsive receptor activity, GPR65 may contribute to cellular responses to changes in the extracellular environment.
A human small cell lung cancer cell line variant derived from the H69 parental line by exposure to doxorubicin (adriamycin). The cells hyperexpress P-glycoprotein and exhibit a multidrug-resistant phenotype characterized by reduced intracellular drug accumulation.
Each knockout cell line is validated by STR authentication, sterility testing (bacteria/fungi), and mycoplasma screening. Genotype is confirmed by two rounds of PCR and Sanger sequencing. Only clones that pass all QC criteria are released, ensuring reliable identity and performance for downstream applications.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?